Moderna and Pfizer Covid vaccines currently unaffordable for India: Medical expert Gagandeep Kang
Both these vaccines are built with messenger RNA technology.
#COVID19 #Vaccine | After Moderna says initial data shows its vaccine is 94.5% effective, Dr. Gagandeep Kang (@GKangInd) tells @ShereenBhan, 'mRNA vaccines are currently unaffordable; India may be able to negotiate a better deal with volumes.' pic.twitter.com/tkfH7eo1Le
— CNBC-TV18 (@CNBCTV18News) November 17, 2020
#COVID19 #Vaccine | As vaccine hopes rise Dr. NK Ganguly, Former Director General, ICMR tells @ShereenBhan, 'India will have to learn & design adult vaccination programme with #COVID19 being the first one.' Catch that conversation at 6 PM on CNBC-TV18 pic.twitter.com/92YnyyMHyz
— CNBC-TV18 (@CNBCTV18News) November 17, 2020
